Last reviewed · How we verify
BAT4706 Injection
At a glance
| Generic name | BAT4706 Injection |
|---|---|
| Also known as | Fc-glycosylated recombinant fully humanized anti-CTLA-4 monoclonal antibody injection |
| Sponsor | Bio-Thera Solutions |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAT4706 Injection CI brief — competitive landscape report
- BAT4706 Injection updates RSS · CI watch RSS
- Bio-Thera Solutions portfolio CI